FDA Approves New Over-the-Counter Pain Reliever Combining Acetaminophen and Naproxen Sodium
The FDA has approved a new over-the-counter pain reliever that combines acetaminophen (the active ingredient in Tylenol) and naproxen sodium (the active ingredient in Aleve). This new medication, Tylenol with Naproxen, is designed to offer fast-acting relief that lasts up…
Nashville, TN, July 31, 2026 —
The U.S. Food and Drug Administration (FDA) has announced the approval of a new over-the-counter pain relief medication. This novel product combines two widely recognized active ingredients: acetaminophen, known as the primary component in Tylenol, and naproxen sodium, the active ingredient found in Aleve.
The newly approved medication, to be marketed as Tylenol with Naproxen, is formulated to provide relief from various minor aches and pains. According to information provided, the drug is designed for fast-acting effects that can last up to 12 hours. This dual-ingredient approach aims to offer a comprehensive solution for pain management.
Availability of Tylenol with Naproxen will be for individuals aged 12 years and older. The medication is intended for the temporary relief of a range of common ailments, including minor arthritis pain, backache, menstrual cramps, the common cold, headache, and muscular aches.
The FDA’s approval process involves a thorough review of safety and efficacy data before a drug can be made available to consumers without a prescription. Further details regarding the specific clinical studies or the exact timeline for market release were not provided in the summary.
Story summarized from the original created by Justin Boggs on www.newschannel5.com, see more information here.
Media gallery
